Replies to post #121163 on Biotech Values

[JJM760]

I am pretty sure that you responded to the SA short piece, am I correct? I happen to agree with you. I am looking for the OBJECTIVE BEAR side. It's been discussed here before, and many do not agree with you (and me).

Thanks, Joe

[biomaven0]

>NEOP

Traditionally, a pivotal trial can only be against an approved agent. That's a kind of head-in-sand approach when the approved agent isn't in fact the SOC, but that's still the world we live in.

Really there are two issues - one is whether they will get FDA approval, and the second is whether the product will be a commercial success.

I don't follow the company or the space at all, but from my quick reading it seems that FDA approval is likely but that commercial success is still quite unclear.

Peter